EUVIMEDEUVIMED entdecken
Fallbericht

Successful Deceased Donor Kidney Transplantation after survived isolated Aspergillus fumigatus Pericarditis using Isavuconazole Prophylaxis: A Case Report

Vishnuvardhan B. R, Madhav H. Hande, Prakash Babu SML, Shilpa Chandran, Meeta Moorjani, Shaik Feema Iffath, Smita Divyaveer

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.40 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Vishnuvardhan B. R und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive fungal infections represent a major challenge in solid organ transplantation due to the risk of reactivation under immunosuppression. Aspergillus pericarditis is an uncommon manifestation associated with high mortality, and data guiding transplant decisions after such infections are limited. Case Presentation: A 48-year-old female with end-stage renal disease on hemodialysis presented with constrictive pericarditis and severe hypotension. Aspergillus fumigatus isolated by tissue culture after subtotal pericardiectomy. She was treated with voriconazole for four months with complete clinical resolution and underwent deceased donor kidney transplantation two months after treatment. The patient required temporary hemodialysis due to immediate postoperative delayed graft function and tacrolimus was started four days later. Secondary prophylaxis from transplantation onwards was with isavuconazole, due to its mild, highly predictable CYP3A4 inhibition that allowed safe titration of calcineurin inhibitors without volatile toxic spikes. Kidney transplantation was successful with no rejection or major infection. Over a 2-year follow-up, the patient had stable allograft function without fungal recurrence.

Conclusion

Kidney transplantation may be feasible in selected patients with previously treated invasive aspergillosis when careful risk stratification, pre-transplant mycological eradication with the strategic deployment of newer-generation triazoles like isavuconazole to safely manage complex post—transplant pharmacokinetic interactions and tailored immunosuppression

Zitieren

APA

R, V. B., Hande, M. H., SML, P. B., Chandran, S., Moorjani, M., Iffath, S. F., & Divyaveer, S. (2026). Successful Deceased Donor Kidney Transplantation after survived isolated Aspergillus fumigatus Pericarditis using Isavuconazole Prophylaxis: A Case Report. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.40

Vancouver

R VB, Hande MH, SML PB, Chandran S, Moorjani M, Iffath SF, et al. Successful Deceased Donor Kidney Transplantation after survived isolated Aspergillus fumigatus Pericarditis using Isavuconazole Prophylaxis: A Case Report. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.40

BibTeX
@article{R2026,
  author = {R, Vishnuvardhan B. and Hande, Madhav H. and SML, Prakash Babu and Chandran, Shilpa and Moorjani, Meeta and Iffath, Shaik Feema and Divyaveer, Smita},
  title = {Successful Deceased Donor Kidney Transplantation after survived isolated Aspergillus fumigatus Pericarditis using Isavuconazole Prophylaxis: A Case Report},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.40}
}
Kostenlos starten →